Insulins in patients with Diabetes Mellitus type 1 and 2. Review
Abstract
Introduction: Diabetes is a non-communicable disease, generated when the pancreas does not produce enough insulin or the organism cannot use it effectively. It is a disease of multiple causes due to endocrine-metabolic alterations, non-communicable, characterized by chronic hyperglycemia and disorders in the metabolism of carbohydrates, fats and proteins. Objective: The objective of this article is to carry out a search to know the different types of insulin, mechanism of action in the body, adverse effects, and importance as a treatment in patients with type 1 and 2 diabetes mellitus in order to offer the patient the best option of insulins to complement your treatment. Methodology: A literature and descriptive review was performed in 20 articles respectively published between 2019 and 2023 being the most current ones. Results and Discussion: Of the 20 articles reviewed, including words such as diabetes, insulins, treatment, resistance, organism, hyperglycemia, a total of 45 articles were found, of which 25 were excluded, based on only 20 of them. Diabetes is one of the major causes of morbidity and mortality, in Mexico the second cause of death is diabetes, mainly in the adult population, in the year 2020. Conclusion: Its current treatment includes the use of insulin, since it is important because it promotes optimal metabolic maintenance with glucose concentrations close to normal, design of physical activities and preparation for behavioral change.
Downloads
References
Ramírez, JRB, Becerra González XM, Jiménez Román XC, Orizaga Trejo JA, Maciel Arellano MR. Aplicación móvil para el control de diabetes [Internet]. Biociencias. 2021;16(2): 63-73. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=8910669
Rivera Rosas CN, Calleja López JRT, Duarte Tagles H, Acuña Hernández MA. COVID-19 y diabetes mellitus: Problema de salud pública en México [Internet]. REMUS. 2021;(6):13-19. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=8852014
López Vaesken AM, Rodríguez Tercero AB, Velázquez Comelli P C. Conocimientos de diabetes y alimentación y control glucémico en pacientes diabéticos de un hospital de Asunción. RCS. 2021;3(1)45-55. Disponible en: http://scielo.iics.una.py/scielo.php?pid=S2664-28912021000100045&script=sci_arttext
Jerez Fernández CI, Medina Pereira YA, Ortiz Chang AS, González Olmedo SI, Aguirre Gaete MC. Fisiopatología y alteraciones clínicas de la diabetes mellitus tipo 2: revisión de literatura. nova [Internet]. 2022;20(38):65-103. https://doi.org/10.22490/24629448.6184
Casas LÁ, Jácome A. Páncreas endócrino. En: Jácome Roca A, Ardila Ardila E, Casas Figueroa LA. Fisiología endocrina, 4ta ed. Manual Moderno; 2022. p. 96.
Kojdamanian Favetto V. Guía NICE 2022: actualización en el manejo de la diabetes mellitus tipo 2 en personas adultas [Internet]. Evid actual pract ambul. 2022;25(2):e007015. https://doi.org/10.51987/evidencia.v25i3.7015
Abdi A, Jalilian M, Ahmadi Sarbarzeh P, Vlaisavljevic Z. Diabetes and Covid-19 [Internet]. Diabetes Res Clin Pract. 2020;166:108347. https://www.sciencedirect.com/science/article/pii/S0168822720305994
Jmenez Montero JG, Villegas Barakat M, Carvajal Solórzano ML. Conceptos Actuales de la Terapia Con Insulina [Internet]. CS. 2022;6(3):65-78. https://doi.org/10.34192/cienciaysalud.v6i3.416
Hernández Rodríguez J. Some Characteristics of Insulin Treatment in Patients with Type 2 Diabetes Mellitus [Internet]. Rev Cubana Med Gen Integr. 2022;38(4): e1836. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252022000400010&lng=es. Epub 01-Dic-2022.
Brink, SJ. Insulin past, present, and future: 100 years from Leonard Thompson [Internet]. Diabetology. 2022;3(1):117-158. https://doi.org/10.3390/diabetology3010010
Mathiesen ER, Ali N, Alibegovic AC, Anastasiou E, Cypryk K, de Valk H, Dores J, Dunne F, Gall M-A, Duran Garcia S, Hanaire HP, Husemoen LLN, Ivanišević M, Kempe H-P, McCance DR, Damm P. Risk of Major Congenital Malformations or Perinatal or Neonatal Death With Insulin Detemir Versus Other Basal Insulins in Pregnant Women With Preexisting Diabetes: The Real-World EVOLVE Study [Internet]. Diabetes Care. 2021;44(9):2069–2077. https://doi.org/10.2337/dc21-0472
Leite L, Leite J, Timbó Barbosa L, do NascimentoI, Sousa-Rodrigues CF, Timbó F. Efetividade dos análogos da insulina comparados às insulinas humanas em gestantes com diabetes mellitus: Revisão sistemática com metanálise [Internet]. Rev Bras Ginecol Obstet. 2019;41:104-115. https://doi.org/10.1055/s-0038-1676510
Lema Solano LL. Análogos de insulina de acción rápida subcutánea vs insulina regular intravenosa para el tratamiento de Cetoacidosis Diabética. Revisión de la literatura [Internet]. Pentaciencias. 2022;4(6):44-56. Disponible en: https://editorialalema.org/index.php/pentaciencias/article/view/333
Freitas LL de, Semeghin CR, Hirata BKS. 100 years of insulin: how the discovery of the hormone revolutionized the treatment of type 1 diabetes [Internet]. RSD. 2021;10(15):e385101522757. Disponible en: from: https://rsdjournal.org/index.php/rsd/article/view/22757
Elías-López D, Ferreira-Hermosillo A. Insulina en poblaciones especiales: resistencia a la insulina, obesidad, embarazo, adultos mayores y enfermedad renal crónica [Internet]. Rev Mex Endocrinol Metab Nutr. 2021;8(93): Suplemento 3. doi: 10.24875/RME.M21000013
Bradley MC, Chillarige Y, Lee H, et al. Severe Hypoglycemia Risk With Long-Acting Insulin Analogs vs Neutral Protamine Hagedorn Insulin [Internet]. JAMA Intern Med. 2021;181(5):598–607. doi:10.1001/jamainternmed.2020.9176
Velasco-Molina IY, Hernández-Hernández AG, Jiménez-Sánchez RC, Moreno ER, Baltazar-Tellez RM, Flores-Chávez OR, Cuevas-Cansino JJ, Arias-Rico J. Déficit Del Autocuidado En El Adulto Mayor Con Diabetes [Internet]. S. F. J. of Dev. 2021;2(5):7515-22. https://doi.org/10.46932/sfjdv2n5-087
Mejia-Montilla J, Reyna-Villasmil N, Bravo-Henríquez A, Fernández-Ramírez A, Reyna-Villasmil E. Vitamina D, síndrome metabólico y diabetes mellitus [Internet]. RVEM. 2022;20(1):19-25. Recuperado de: https://www.redalyc.org/articulo.oa?id=375570662003
Vintimilla Enderica PF, Giler Mendoza YO, Motoche Apolo KE, Ortega Flores JJ. Diabetes Mellitus Tipo 2: Incidencias, Complicaciones y Tratamientos Actuales [Internet]. RECIMUNDO. 2019;3(1):26-7. https://doi.org/10.26820/recimundo/3.(1).enero.2019.26-37
Gómez-Pérez, FJ, Ríos-Torres JM, Cárdenas-Fragoso JL, Tovar-Méndez VH. Evolución histórica de las moléculas de insulina empleadas en el tratamiento de la diabetes [Internet]. Rev Mex Endocrinol Metab Nutr. 2021;8:(SUPL. 3):19-28. DOI: 10.24875/RME.M21000017
Arteaga Delgado CE, Casahualpa Leones RI, Gutiérrez Rivera FW, Santistevan Holguin JB, Mitte Baque YS, Figueroa Parrales AA. Enfoque sobre los factores de riesgo más relevantes de la diabetes en niños [Internet]. RECIMUNDO. 2019;2(4):270-97. Disponible en: https://www.recimundo.com/index.php/es/article/view/353
Guardado-Mendoza R, Vargas-Ortiz K, Reyes-Escogido M de L, Rodríguez-Cortés R, Evia-Viscarra L. Prediabetes, undiagnosed T2D, insulin resistance and metabolic syndrome in Guanajuato, Mexico [Internet]. Salud Publica Mex. 2024;66(3):288-95. Disponible en: https://saludpublica.mx/index.php/spm/article/view/15414
Copyright (c) 2024 María F. Segura Soto, Jose Rico, Flor I. Castillo, Nohemi Santos Villegas, Reyna C. Jiménez Sánchez, Rosa M. Baltazar Téllez, Araceli Cano
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
